Cargando…
Resistance to chemoimmunotherapy in non-small-cell lung cancer
Recent clinical trials evaluating the combination of chemotherapy with immune checkpoint inhibition for the primary treatment of lung cancer showed increased progression-free and overall survival compared with chemotherapy alone. However, the combination of these two modalities is less than additive...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
OAE Publishing Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992480/ https://www.ncbi.nlm.nih.gov/pubmed/35582443 http://dx.doi.org/10.20517/cdr.2020.09 |